糖尿病前期1年内进展为糖尿病或逆转为血糖正常者的蛋白质组与代谢组特征
研究比较了新发糖尿病、糖尿病前期和正常糖耐量人群的血浆蛋白质组与代谢组,并对108名基线均为糖尿病前期的参与者分析1年前样本。发现二羰基/L-木酮糖还原酶和谷胱甘肽S-转移酶A3较高与1年后糖尿病风险增加相关,免疫反应通路与糖尿病前期转归轨迹相关。
要点
- 糖尿病前期状态下二羰基/L-木酮糖还原酶和谷胱甘肽S-转移酶A3较高与1年后糖尿病风险增加相关。
- 新发糖尿病者口服葡萄糖耐量试验中IDL颗粒、IDL载脂蛋白B和IDL胆固醇的浓度曲线下面积高于血糖正常者。
- 免疫反应通路差异在基线糖尿病前期状态时即可识别,并与糖尿病前期转归轨迹相关。
核心结论
- 研究识别了与糖尿病前期进展为糖尿病或逆转为血糖正常相关的新候选标志物,调节免疫反应的通路与糖尿病前期转归轨迹相关。
研究设计与样本
- 测量了多达134名新发糖尿病、糖尿病前期或正常糖耐量个体的空腹血浆1389种蛋白质浓度,以及空腹、30分钟和120分钟口服葡萄糖耐量试验血浆152种代谢物浓度。
- 对108名参与者,重复分析了1年前的样本,当时所有人均为糖尿病前期。
主要发现
- 在1年前均为糖尿病前期的人群中,糖尿病者14种血浆蛋白质浓度高于血糖正常者,且与胰岛素敏感性指标相关。
- 糖尿病前期状态下二羰基/L-木酮糖还原酶和谷胱甘肽S-转移酶A3水平较高与1年后糖尿病风险增加相关。
- 通路分析提示糖尿病与血糖正常者之间存在免疫反应差异,该差异在1年前基线糖尿病前期状态时即可识别。
- 新发糖尿病者口服葡萄糖耐量试验中IDL颗粒、IDL载脂蛋白B和IDL胆固醇浓度的曲线下面积高于血糖正常者。
- 谷氨酸浓度在进展为糖尿病的糖尿病前期者中升高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Progression of prediabetes to type 2 diabetes has been associated with β-cell dysfunction, whereas its remission to normoglycemia has been related to improvement of insulin sensitivity. To understand the mechanisms and identify potential biomarkers related to prediabetes trajectories, we compared the proteomics and metabolomics profile of people with prediabetes progressing to diabetes or reversing to normoglycemia within 1 year. RESEARCH DESIGN AND METHODS: The fasting plasma concentrations of 1,389 proteins and the fasting, 30-min, and 120-min post-oral glucose tolerance test (OGTT) plasma concentrations of 152 metabolites were measured in up to 134 individuals with new-onset diabetes, prediabetes, or normal glucose tolerance. For 108 participants, the analysis was repeated with samples from 1 year before, when all had prediabetes. RESULTS: The plasma concentrations of 14 proteins were higher in diabetes compared with normoglycemia in a population with prediabetes 1 year before, and they correlated with indices of insulin sensitivity. Higher levels of dicarbonyl/L-xylulose reductase and glutathione S-transferase A3 in the prediabetic state were associated with an increased risk of diabetes 1 year later. Pathway analysis pointed toward differences in immune response between diabetes and normoglycemia that were already recognizable in the prediabetic state 1 year prior at baseline. The area under the curve during OGTT of the concentrations of IDL particles, IDL apolipoprotein B, and IDL cholesterol was higher in new-onset diabetes compared with normoglycemia. The concentration of glutamate increased in prediabetes progressing to diabetes. CONCLUSIONS: We identify new candidates associated with the progression of prediabetes to diabetes or its remission to normoglycemia. Pathways regulating the immune response are related to prediabetes trajectories.
引用
- Barovic M, Hahn JJ, Heinrich A, et al. Proteomic and Metabolomic Signatures in Prediabetes Progressing to Diabetes or Reversing to Normoglycemia Within 1 Year. Diabetes Care. 2025. PMID: 39746149. doi:10.2337/dc24-1412
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。